Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26100001
- Awardee
-
American Peptide Company Inc. UEI NEKKLUGDMBJ3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,250
Award facts
- Contract value 100% obligated
- $8,250.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Windsor Mill, Milford Mill, MD 21244, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a Blanket Purchase Agreement (BPA) call to American Peptide Company Inc. on May 15, 2014, for the supply of drugs and biologicals. The contract, which carries a ceiling value of $8,250.00, operates under firm fixed price terms with no set-aside designation. Performance will take place at the contractor's facility in Windsor Mill/Milford Mill, Maryland. This BPA call represents a task order or individual purchase against an existing blanket purchase agreement vehicle, allowing the government to acquire pharmaceutical and biological products as needed within the specified ceiling amount.
American Peptide Company Inc., operating as a subsidiary entity (UEI: NEKKLUGDMBJ3), was selected to fulfill the National Cancer Institute's requirements for drugs and biologicals, with an ultimate completion date of June 12, 2014. The relatively modest contract value and defined completion timeframe suggest this represented a specific, short-term procurement need within the Institute's broader research and treatment support operations. The use of a BPA call mechanism indicates this vendor was already part of an established government procurement vehicle, streamlining the acquisition process for this particular requirement.
Quick answers
Who was awarded contract HHSN26100001?
HHSN26100001 was awarded to American Peptide Company Inc. by National Cancer Institute (National Institutes of Health) on May 15, 2014.
How much is contract HHSN26100001 worth?
The government has obligated $8,250 on HHSN26100001.
Is contract HHSN26100001 an order under another contract?
Yes. HHSN26100001 is a BPA call under HHSN263199800049468B, a blanket purchase agreement.
Was contract HHSN26100001 competed?
The extent of competition for HHSN26100001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award